X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
female (25) 25
humans (25) 25
male (19) 19
adult (17) 17
index medicus (16) 16
middle aged (14) 14
ribavirin (14) 14
hepatitis (13) 13
hepatitis c (13) 13
hepatitis c, chronic - drug therapy (12) 12
gastroenterology & hepatology (11) 11
hepacivirus - genetics (11) 11
interferon (11) 11
treatment outcome (11) 11
antiviral agents - adverse effects (10) 10
drug therapy, combination (10) 10
genotype (10) 10
aged (9) 9
hepatitis c virus (9) 9
cirrhosis (8) 8
health aspects (8) 8
interferon-alpha - therapeutic use (8) 8
obstetrics & gynecology (8) 8
recombinant proteins (8) 8
antiviral agents - administration & dosage (7) 7
antiviral agents - therapeutic use (7) 7
combination therapy (7) 7
drug administration schedule (7) 7
genetic aspects (7) 7
infections (7) 7
interferon-alpha - adverse effects (7) 7
ribavirin - administration & dosage (7) 7
ribavirin - adverse effects (7) 7
adolescent (6) 6
antiviral agents (6) 6
chronic infection (6) 6
gastroenterology and hepatology (6) 6
genotype & phenotype (6) 6
genotypes (6) 6
infection (6) 6
interferon-alpha - administration & dosage (6) 6
patients (6) 6
polyethylene glycols - adverse effects (6) 6
reproductive biology (6) 6
ribavirin - therapeutic use (6) 6
united states (6) 6
abridged index medicus (5) 5
anemia (5) 5
care and treatment (5) 5
hepatitis c, chronic - virology (5) 5
medicine, general & internal (5) 5
polyethylene glycols - administration & dosage (5) 5
polyethylene glycols - therapeutic use (5) 5
rna, viral - blood (5) 5
anemia - chemically induced (4) 4
combination (4) 4
dose-response relationship, drug (4) 4
drug therapy (4) 4
follow-up studies (4) 4
hepatitis c - drug therapy (4) 4
pregnancy (4) 4
therapy (4) 4
viral load (4) 4
virus diseases (4) 4
virus-infection (4) 4
viruses (4) 4
young adult (4) 4
chronic hepatitis-c (3) 3
direct-acting antivirals (3) 3
hepatitis c - virology (3) 3
hepatology (3) 3
interferon-alpha-2b plus ribavirin (3) 3
life sciences (3) 3
liver cirrhosis (3) 3
medical colleges (3) 3
obstetrics and gynecology (3) 3
peginterferon alpha-2a (3) 3
plus ribavirin (3) 3
recombinant proteins - administration & dosage (3) 3
recombinant proteins - adverse effects (3) 3
retreatment (3) 3
telaprevir (3) 3
time factors (3) 3
[sdv]life sciences [q-bio] (2) 2
aged, 80 and over (2) 2
alanine (2) 2
alanine transaminase (2) 2
antiretroviral drugs (2) 2
benzimidazoles - therapeutic use (2) 2
biological products industry (2) 2
biological response modifiers (2) 2
clinical trials (2) 2
digestive system diseases (2) 2
double-blind (2) 2
double-blind method (2) 2
drug dosages (2) 2
drug resistance, viral (2) 2
drug therapy, combination - methods (2) 2
elbasvir (2) 2
erythropoietin - adverse effects (2) 2
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Lancet Infectious Diseases, The, ISSN 1473-3099, 2012, Volume 12, Issue 9, pp. 671 - 677
Journal Article
Hepatology, ISSN 0270-9139, 08/2017, Volume 66, Issue 2, pp. 389 - 397
Journal Article
Journal of Hepatology, ISSN 0168-8278, 02/2016, Volume 64, Issue 2, pp. 301 - 307
Journal Article
Journal of medical virology, 03/2019
Despite high efficacy of current direct-acting antiviral agents (DAAs) in treating chronic HCV infection, a small portion of patients fail treatment. QUARTZ-I... 
Journal Article
Clinical Liver Disease, ISSN 2046-2484, 07/2017, Volume 10, Issue 1, pp. 1 - 3
Watch a video presentation of this article 
Journal Article
The American Journal of Medicine, ISSN 0002-9343, 1999, Volume 107, Issue 6, pp. 100 - 103
The hepatitis C epidemic has extended well into the correctional population where individuals predominantly originate from high-risk environments and have... 
United States - epidemiology | Hepatitis C - therapy | Hepatitis C - epidemiology | Humans | Risk Factors | Female | Male | Hepatitis C - prevention & control | Hepatitis C - transmission | Prisoners - statistics & numerical data | Demographic aspects | Hepatitis C | Prisoners | Diseases
Journal Article
Journal of Gastroenterology and Hepatology, ISSN 0815-9319, 02/2006, Volume 21, Issue 2, pp. 406 - 412
Background:  Peginterferon α‐2a (40 kDa) plus ribavirin is equally effective in chronic hepatitis C patients with normal or elevated alanine aminotransferase... 
health‐related quality of life | combination therapy | ribavirin | peginterferon α‐2a | persistently normal ALT levels | Health-related quality of life | Persistently normal ALT levels | Combination therapy | Peginterferon α-2a | Ribavirin
Journal Article
Journal Article
The American Journal of Medicine, ISSN 0002-9343, 12/1999, Volume 107, Issue 6B, p. 100S
  The hepatitis C epidemic has extended well into the correctional population where individuals predominantly originate from high-risk environments and have... 
Hepatitis | Population | Viruses | Infections
Journal Article
Gastroenterology, ISSN 0016-5085, 2003, Volume 124, Issue 4, pp. A795 - A795
Journal Article
Journal Article
Journal of Gastrointestinal Surgery, ISSN 1091-255X, 2003, Volume 7, Issue 2, pp. 317 - 317
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.